Overactive bladder: an update

被引:80
作者
Hashim, Hashim [1 ]
Abrams, Paul [1 ]
机构
[1] Southmead Hosp, Bristol Urol Inst, Bristol BS10 5NB, Avon, England
关键词
frequency/volume charts; overactive bladder; prevalence; quality of life; treatment;
D O I
10.1097/MOU.0b013e32819ed7f9
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose of review Overactive bladder is an important lower urinary tract syndrome that negatively affects the quality of life of millions of people worldwide. Both sexes and all age groups may be affected; therefore many specialists, including urologists, gynaecologists, geriatricians, paediatricians, physiotherapists and continence advisors, are involved in the management of patients with overactive bladder. Recent findings There is ongoing research, both basic science and clinical trials, to establish the cause of overactive bladder and to determine the best method of managing patients who suffer from this syndrome. New theories and modified definitions of overactive bladder have been proposed, structured evidence-based management guidelines have been established, more prevalence studies have been conducted and new treatment strategies have emerged. Summary Overactive bladder is now recognized as a chronic debilitating condition that costs millions of dollars. With an ageing population these costs will increase, and it is necessary that health systems around the world recognize this. Further research into the basic science of the condition is required to identify the true cause of overactive bladder, allowing new targeted treatments to be established.
引用
收藏
页码:231 / 236
页数:6
相关论文
共 42 条
  • [1] Abrams P, 2005, INCONTINENCE, VOLS 1 AND 2, P1589
  • [2] Abrams P, 2006, NEUROUROL URODYNAM, V25, P293, DOI 10.1002/nau.20251
  • [3] The International Consultation on Incontinence Modular Questionnaire: www.iciq.net
    Abrams, P
    Avery, K
    Gardener, N
    Donovan, J
    [J]. JOURNAL OF UROLOGY, 2006, 175 (03) : 1063 - 1066
  • [4] Abrams P, 1996, SCAND J UROL NEPHROL, V30, P47
  • [5] Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052
  • [6] Abrams P, 2000, AM J MANAG CARE, V6, pS580
  • [7] Andersson KE, 2005, INCONTINENCE, VOLS 1 AND 2, P809
  • [8] Badaw JK, 2006, PHARMAZIE, V61, P175
  • [9] A myogenic basis for the overactive bladder
    Brading, AF
    [J]. UROLOGY, 1997, 50 (6A) : 57 - 67
  • [10] Brown JS, 2000, AM J MANAG CARE, V6, pS574